Filter by
NewsHaving IMPACTT 2022: The Rosell® Institute for Microbiome and Probiotics Renews Its Platinum SponsorshipThe Rosell® Institute for Microbiome and Probiotics by Lallemand reconducts its platinum sponsorship of the Canadian microbiome symposium, Having IMPACTT, for a second year in a row. Having IMPACTT 2: Advancing Microbiome Research will take place June 2 and 3, […]
May 26, 2022
NewsLallemand Health Solutions: Gold Sponsor of Probiota AmericasAs Gold Sponsor, Lallemand Health Solutions is supporting the IPA World Congress + Probiota Americas, presented by NUTRAIngredients-USA.com. This major annual event for the prebiotic, probiotic and the microbiota will take place on June 1-3, 2022, in Washington, DC. As […]
May 24, 2022
NewsInnovative Health Claims Approved by Authorities Confirms Benefits of L. rhamnosus HA-114 to Support Weight Management EffortsLallemand Health Solutions has gained innovative indications for its probiotic strain L. rhamnosus HA-114 from Health Canada, recognizing its beneficial impact to support people’s efforts when engaged in a weight management program, at a daily dose of 10B CFU. This […]
May 11, 2022
NewsVitafoods Europe 2022: All Lights on Metabolic, Women’s, Mental and Gut HealthLallemand Health Solutions’ team has some amazing novelties to tell you about at Vitafoods Europe in Geneva Palexpo, Switzerland from May 10-12, 2022. L. rhamnosus HA-114 supports weight management efforts First and foremost, come hear about probiotic strain L. rhamnosus HA-114 […]
May 2, 2022
NewsLive presentation about a unique three-strain synbiotic to support immune health at SupplySide® Sponsored Intensive, April 20, 2022Join in to watch Lucie Lingrand, Product Manager at Lallemand Health Solutions live presentation about a unique three-strain synbiotic to support immune health Probiokid®: The Probiotic Superhero for Infants and Children. This presentation will outline the uniqueness of a time-tested […]
Apr 13, 2022
NewsLallemand Health Solutions at Pharmabiotics: Join in To Learn More About Discovery, Development & Preclinical ResearchAnnie Tremblay, Scientific Writer at Lallemand Health Solutions will present “Preclinical and Clinical Studies Shed Light on Potential Modes of Action of L. rhamnosus HA-114 in Metabolic Regulation and Neuroprotection” at the Pharmabiotics Conference and Partnering 2022, in Lyon, France, […]
Apr 11, 2022
NewsLallemand Health Solutions There to Support the Emerging Science of The MicrobiotaLallemand Health Solutions is confirmed as a leader in the microbiota-related industry, with its comprehensive expertise in microbial fermentation, from the research and development phase to the production and marketing of food supplements as well as medication. Indeed, in this […]
Mar 30, 2022
NewsNPEW 2022: Lallemand Health Solutions to Present Innovative Probiotic Strains and FormulationsLallemand Health Solutions’ team will be happy to meet and greet you at booth #4370 during the Natural Products Expo West in Anaheim, California, from March 8 to 12 2022. During this important industry gathering, innovative probiotic strain and formulations […]
Mar 1, 2022
NewsNEW Approved Canadian Claim: L. paracasei HA-196 Helps Support Healthy Bowel Habits in Adults With IBSLallemand Health Solutions has gained new indication for its probiotic strain L. paracasei HA-196 from Health Canada recognizing its beneficial effects to help support healthy bowel habits in adults with irritable bowel symptoms (IBS), at a daily dose 10B CFU. […]
Feb 28, 2022
NewsSylvie Binda, Vice-President R&D of Lallemand Health Solutions Appointed Vice-President of The New Office of The Alliance Promotion MicrobioteAlready a member of the board of directors of the Alliance Promotion Microbiote (APM), Sylvie Binda, Vice-President Research and Development of Lallemand Health Solutions, has been appointed Vice-President of the new office of the APM, following the General Meeting held […]
Feb 16, 2022